Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918

This article has now been updated. Please use the final version.

An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
Tomohiro HosodaYuki UeharaToshio Naito
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 3498-19

Details
Abstract

Patients with HIV infection represent a high-risk group for medication overdose because of the high frequency of complicating psychiatric disorders. Raltegravir is well-known for its low frequency of adverse effects. We herein report a 42-year-old Japanese man with HIV infection who was hospitalized 6 hours after overdosing with 24,000 mg of raltegravir in a suicide attempt. No serious adverse events occurred, although the plasma concentration of raltegravir at 18 hours after the overdose was 79,871.1 ng/mL. Raltegravir may be well-indicated for HIV patients at risk of overdosing.

Content from these authors
© 2020 by The Japanese Society of Internal Medicine
feedback
Top